Our flexibility and reactivity were key for In’Tech which was looking for a partner that could match its growth momentum.
In’Tech Medical manufactures orthopedic surgical tools to be used in the fast-growing spinal surgery sector. The group is a world leader in the knees, shoulders and hips markets. It currently has 800 employees and operations in France, the USA and Malaysia. With two-thirds of its turnover generated in the US market, In’Tech Medical is a key international player.
InTech’Medical underwent an LBO with TCR in 2012. In 2017, Eurazeo PME and the management team were looking for a private lender to provide senior debt in order to finance Eurazeo PME’s acquisition of the company. They sought a private lender in order to keep the process confidential, manage the short timeframe and provide the company with a tailor-made and flexible structure.
Following the 2017 LBO with Eurazeo, InTech’Medical’s ambition is to continue consolidating its market share in the spine segment, further diversify its product portfolio and expand its geographic coverage notably in Asia and the USA. This strategy will rely on both organic growth and an active build-up strategy.
We had already met up with In’tech in 2011 and were therefore quite familiar with the company as well as the market as we had invested in Marle, a leading manufacturer of hip and knee implants, in 2014.
So our knowledge of the company and the market enabled us to be very reactive and position ourselves to arrange a senior secured financing package. Our ability to execute the transaction in a short timeframe and provide a flexible debt instrument made us the partner of choice for Eurazeo-PME and Intech.
16Sep’ 2021CAPZA Expansion supports Big Mamma in its development in France and in EuropeCAPZA Expansion and Zencap are supporting the French group of Italian restaurants Big Mamma.Read more
22Jul’ 2021CAPZA Expansion invests in the French industrial group NovarcCAPZA Expansion enters the capital of Novarc to back the Group in its "CAP 2025" strategic plan.Read more
21Jul’ 2021CAPZA Transition supports the NORCAN groupCAPZA Transition reinforces the transformation of the NORCAN Group and the development of the SHERPA® range alongside its management and its historical shareholdersRead more
15Jul’ 2021CAPZA exits Ivnosys after supporting the group's growthCAPZA sold its minority stake in Ivnosys, a Spanish leading e-identity company.Read more